Latest Articles

Publication Date
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer - OncLive

SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer OncLive

Published: July 24, 2025, 1:49 p.m.
The Role of Plant-Based Diets and Personalized Nutrition in Endometriosis Management: A Review.

Endometriosis is a chronic, estrogen-dependent inflammatory condition that affects multiple organ systems and significantly impairs the quality of life in women of reproductive age. While conventional hormonal therapies may alleviate …

Published: July 13, 2025, midnight
Patient Safety Network Papers Restored Amid Lawsuit From Doctors - MSN

Patient Safety Network Papers Restored Amid Lawsuit From Doctors MSN

Published: June 18, 2025, 6:06 p.m.
Patient Safety Network Papers Restored Amid Lawsuit From Doctors - MedPage Today

Patient Safety Network Papers Restored Amid Lawsuit From Doctors MedPage Today

Published: June 17, 2025, 8:38 p.m.
Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial.

To evaluate the safety and pharmacokinetics/pharmacodynamics of AMY109, an anti-interleukin-8 recycling antibody in a first-in-human phase 1 trial in healthy volunteers (HVs) and patients with endometriosis.

Published: May 2, 2025, midnight
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive

Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive

Published: April 28, 2025, 1:18 p.m.
Efficacy and Safety of Robotic Surgery With Sentinel Lymph Node Navigation in Obese Patients With Endometrial Cancer: A Retrospective Study - Cureus

Efficacy and Safety of Robotic Surgery With Sentinel Lymph Node Navigation in Obese Patients With Endometrial Cancer: A Retrospective Study Cureus

Published: April 16, 2025, 6:31 a.m.
Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer - OncLive

Dr Lee on the Preliminary Safety of Nivolumab for Resectable dMMR Endometrial Cancer OncLive

Published: April 14, 2025, 6:31 p.m.
Intra-ovarian injection of autologous menstrual blood-derived-mesenchymal stromal cells: a safe and promising method to improve pregnancy rate in poor ovarian responders.

Poor ovarian response (POR) significantly reduces the success rates of fertility treatments. This study investigates the long-term efficacy and potential complications associated with autologous menstrual blood-derived mesenchymal stromal cells (MenSCs) …

Published: April 12, 2025, midnight
Popular Meat Product Recalled In Ohio Poses Safety Risk - iHeart

Popular Meat Product Recalled In Ohio Poses Safety Risk iHeart

Published: April 10, 2025, 8:37 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!